MULTIPLE MYELOMA REFRACTORY
Clinical trials for MULTIPLE MYELOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA REFRACTORY trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug tested for patients Who've run out of options
Disease control ENROLLING_BY_INVITATIONThis study is testing whether adding a new antibody drug called HuL001 to standard medications (lenalidomide and dexamethasone) can help control multiple myeloma that has returned or stopped responding to previous treatments. The trial will enroll 21 patients who have already tri…
Matched conditions: MULTIPLE MYELOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Can an app empower cancer patients?
Knowledge-focused OngoingThis study is testing whether using a digital health platform called All4Cure helps people with multiple myeloma feel more in control of their health. About 200 participants will fill out surveys over a year to measure their engagement and symptom burden. The goal is to see if th…
Matched conditions: MULTIPLE MYELOMA REFRACTORY
Sponsor: All4Cure • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC